NCT00003746View on ClinicalTrials.gov

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2010

Conditions
Leukemia
Interventions
DRUG

2-chlorodeoxyadenosine (CDA) daily

Daily administration

DRUG

2-chlorodeoxyadenosine weekly

Weekly administration

Trial Locations (1)

CH-3010

Inselspital Bern, Bern

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER